a man laying in a hospital bed being examined by a nurse
Bagoes Ilhamy (Unsplash) / Unsplash License
Original
Clinical Trials/November 10, 2026/3 min read

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

  • A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — RECRUITING, PHASE3. Interventions: Baricitinib, Placebo. Locations: Santa Barbara, California, United States | Tallahassee, Florida, United States | Iowa City, Iowa, United States. The purpose of this study is to find o...Source
  • Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System — RECRUITING, NA. Interventions: Omnipod 5 System, Omnipod 6 System. Locations: Los Angeles, California, United States | Santa Barbara, California, United States | Aurora, Colorado, United States. This multi-center, rando...Source
  • Simultaneous Measurement and Responsive Treatment - Part 2 — RECRUITING, EARLY_PHASE1. Interventions: DPP System (Insulin Pump and Continuous Glucose Monitoring Platform). Locations: Toronto, Ontario, Canada. This research study is testing an investigational dual-port insulin pat...Source
  • Tirzepatide Use in People With Obesity and Type 1 Diabetes — RECRUITING, PHASE4. Interventions: Tirzepatide, Placebo. Locations: Kuwait City, Sharq, Kuwait. Tirzepatide, a gut hormone-based medication, has shown promising results in treating obesity, with \~22% weight loss and mi...Source
  • Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes — RECRUITING. Interventions: Biomarker and Echocardiographic Assessment. Locations: Thessaloniki, Central Makedonia, Greece. Diabetic ketoacidosis (DKA) is a severe metabolic complication in children with newly diagnosed...Source
  • Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge — RECRUITING, NA. Interventions: Libre 3 Plus Continuous Glucose Monitor, Dexcom G7 Continuous Glucose Monitor. Locations: Nashville, Tennessee, United States. This study aims to improve patient awareness of the utility o...Source
  • Discovery Diabetes — RECRUITING, NA. Interventions: Discovery Program. Locations: Nashville, Tennessee, United States. The goal of this clinical trial is to learn if the Discovery Program can help improve diabetes management in adolescents...Source
  • Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State — RECRUITING, PHASE1. Interventions: GZR-33. Locations: Neuss, Germany | Neuss, Germany. This trial intends to investigate the pharmacodynamics, pharmacokinetics, safety, and tolerability of insulin GZR33 (hereafter refer...Source

Questions before contacting a study

  • Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
  • What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
  • Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.

Plain-language summaries of published studies on the same subject.